NOV Q1 2026 Earnings EPS Falls Short of Estimates Amid Challenging Conditions MC Q1 2026 Earnings EPS Falls Short of Estimates Amid Challenging Advisory Environment Altimmune Q1 2026 Earnings EPS Beats Estimates Amid Continued Pipeline Development Revelation Biosciences Q1 2026 Earnings EPS Miss Highlights Ongoing PreRevenue Stage STEL Q1 2026 Earnings EPS Beat Drives Modest Stock Uptick STZ Q1 2026 Earnings EPS Surprises to the Upside Stock Slips